Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients
NCT01455675
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
164
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
IgY
DRUG:
Placebo
Sponsor
Mukoviszidose Institut gGmbH